26 results on '"Blazey, T"'
Search Results
2. Putting Forecasts to Work in the Firm
- Author
-
Blazey, T. W.
- Published
- 1976
3. Spatially distinct atrophy is linked to -amyloid and tau in preclinical Alzheimer disease
- Author
-
Wang, L., primary, Benzinger, T. L., additional, Hassenstab, J., additional, Blazey, T., additional, Owen, C., additional, Liu, J., additional, Fagan, A. M., additional, Morris, J. C., additional, and Ances, B. M., additional
- Published
- 2015
- Full Text
- View/download PDF
4. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease
- Author
-
Benzinger, TLS, Blazey, T, Jack, CR, Koeppe, RA, Su, Y, Xiong, C, Raichle, ME, Snyder, AZ, Ances, BM, Bateman, RJ, Cairns, NJ, Fagan, AM, Goate, A, Marcus, DS, Aisen, PS, Christensen, JJ, Ercole, L, Hornbeck, RC, Farrar, AM, Aldea, P, Jasielec, MS, Owen, CJ, Xie, X, Mayeux, R, Brickman, A, McDade, E, Klunk, W, Mathis, CA, Ringman, J, Thompson, PM, Ghetti, B, Saykin, AJ, Sperling, RA, Johnson, KA, Salloway, S, Correia, S, Schofield, PR, Masters, CL, Rowe, C, Villemagne, VL, Martins, R, Ourselin, S, Rossor, MN, Fox, NC, Cash, DM, Weiner, MW, Holtzman, DM, Buckles, VD, Moulder, K, Morris, JC, Benzinger, TLS, Blazey, T, Jack, CR, Koeppe, RA, Su, Y, Xiong, C, Raichle, ME, Snyder, AZ, Ances, BM, Bateman, RJ, Cairns, NJ, Fagan, AM, Goate, A, Marcus, DS, Aisen, PS, Christensen, JJ, Ercole, L, Hornbeck, RC, Farrar, AM, Aldea, P, Jasielec, MS, Owen, CJ, Xie, X, Mayeux, R, Brickman, A, McDade, E, Klunk, W, Mathis, CA, Ringman, J, Thompson, PM, Ghetti, B, Saykin, AJ, Sperling, RA, Johnson, KA, Salloway, S, Correia, S, Schofield, PR, Masters, CL, Rowe, C, Villemagne, VL, Martins, R, Ourselin, S, Rossor, MN, Fox, NC, Cash, DM, Weiner, MW, Holtzman, DM, Buckles, VD, Moulder, K, and Morris, JC
- Abstract
Major imaging biomarkers of Alzheimer's disease include amyloid deposition [imaged with [(11)C]Pittsburgh compound B (PiB) PET], altered glucose metabolism (imaged with [(18)F]fluro-deoxyglucose PET), and structural atrophy (imaged by MRI). Recently we published the initial subset of imaging findings for specific regions in a cohort of individuals with autosomal dominant Alzheimer's disease. We now extend this work to include a larger cohort, whole-brain analyses integrating all three imaging modalities, and longitudinal data to examine regional differences in imaging biomarker dynamics. The anatomical distribution of imaging biomarkers is described in relation to estimated years from symptom onset. Autosomal dominant Alzheimer's disease mutation carrier individuals have elevated PiB levels in nearly every cortical region 15 y before the estimated age of onset. Reduced cortical glucose metabolism and cortical thinning in the medial and lateral parietal lobe appeared 10 and 5 y, respectively, before estimated age of onset. Importantly, however, a divergent pattern was observed subcortically. All subcortical gray-matter regions exhibited elevated PiB uptake, but despite this, only the hippocampus showed reduced glucose metabolism. Similarly, atrophy was not observed in the caudate and pallidum despite marked amyloid accumulation. Finally, before hypometabolism, a hypermetabolic phase was identified for some cortical regions, including the precuneus and posterior cingulate. Additional analyses of individuals in which longitudinal data were available suggested that an accelerated appearance of volumetric declines approximately coincides with the onset of the symptomatic phase of the disease.
- Published
- 2013
5. Hyperglycemia selectively increases cerebral non-oxidative glucose consumption without affecting blood flow.
- Author
-
Blazey T, Lee JJ, Snyder AZ, Goyal MS, Hershey T, Arbeláez AM, and Raichle ME
- Abstract
Multiple studies have shown that hyperglycemia increases the cerebral metabolic rate of glucose (CMRglc) in subcortical white matter. This observation remains unexplained. Using positron emission tomography (PET) and euinsulinaemic glucose clamps, we found, for the first time, that acute hyperglycemia increases non-oxidative CMRglc (i.e., aerobic glycolysis (AG)) in subcortical white mater as well as in medial temporal lobe structures, cerebellum and brainstem, all areas with low euglycemic CMRglc. Surprisingly, hyperglycemia did not change regional cerebral blood flow (CBF), the cerebral metabolic rate of oxygen (CMRO
2 ), or the blood-oxygen-level-dependent (BOLD) response. Regional gene expression data reveal that brain regions where CMRglc increased have greater expression of hexokinase 2 ( HK2 ). Simulations of glucose transport revealed that, unlike hexokinase 1, HK2 is not saturated at euglycemia, thus accommodating increased AG during hyperglycemia.- Published
- 2024
- Full Text
- View/download PDF
6. Hyperpolarized 15 N caffeine, a potential probe of liver function and perfusion.
- Author
-
von Morze C, Shaw A, and Blazey T
- Subjects
- Animals, Rats, Male, Magnetic Resonance Imaging, Brain diagnostic imaging, Brain metabolism, Rats, Sprague-Dawley, Magnetic Resonance Spectroscopy, Liver Function Tests, Caffeine pharmacology, Caffeine chemistry, Liver diagnostic imaging, Liver metabolism, Nitrogen Isotopes
- Abstract
Purpose: To demonstrate hyperpolarization of
15 N-caffeine and report exploratory findings as a potential probe of liver function and perfusion., Methods: An amorphous formulation of [1,3-15 N2 ]caffeine was developed for hyperpolarization via dissolution dynamic nuclear polarization. Polarizer hardware was augmented to support monitoring of solid-state15 N MR signals during the buildup of hyperpolarization. Liquid state hyperpolarized15 N MR signals were obtained in a preclinical 3T magnet by interfacing an external spectrometer console with home-built RF surface coils.15 N signal decay constants were estimated in H2 O and in vivo in liver and brain regions of rats at 3 T. Decays were also measured at 9.4 T to assess the effect of B0 , and in the presence of albumin to assess the impact of protein binding., Results: Polarization levels of 3.5% and aqueous T1 relaxation times of nearly 200 s were attained for both N1 and N3 positions at 3 T. Shorter apparent decay constants were observed in vivo, ranging from 25 s to 43 s, with modest extensions possible by exploiting competitive binding of iophenoxate with plasma albumin. Downstream products of caffeine could not be detected on in vivo15 N-MR spectra of the liver region, even with metabolic stimulation by β $$ \beta $$ -naphthoflavone treatment. Considering the high perfusion rate of brain, persistence of caffeine signal in this region is consistent with potential value as a perfusion imaging agent., Conclusion: These results establish the feasibility of hyperpolarization of hyperpolarized15 N-caffeine, but further work is necessary to establish the role of this new agent to probe liver metabolism and perfusion., (© 2024 International Society for Magnetic Resonance in Medicine.)- Published
- 2024
- Full Text
- View/download PDF
7. A vendor-neutral EPI sequence for hyperpolarized 13 C MRI.
- Author
-
Blazey T, Shaw A, and von Morze C
- Subjects
- Echo-Planar Imaging, Magnetic Resonance Imaging methods, Image Processing, Computer-Assisted methods, Lactic Acid chemistry, Algorithms, Humans, Phantoms, Imaging, Pyruvic Acid chemistry, Pyruvic Acid metabolism, Carbon Isotopes chemistry
- Abstract
Purpose: To develop a flexible, vendor-neutral EPI sequence for hyperpolarized
13 C metabolic imaging., Methods: An open-source EPI sequence consisting of a metabolite-specific spectral-spatial RF excitation pulse and a customizable EPI readout was created using the Pulseq framework. To explore the flexibility of our sequence, we tested several versions of the sequence including a symmetric 3D readout with different spatial resolutions for each metabolite (1.0 cm3 and 1.5 cm3 ). A multichamber phantom constructed with a Shepp-Logan geometry, containing two chambers filled with either natural abundance13 C compounds or hyperpolarized (HP) [1-13 C]pyruvate, was used to test each sequence. For experiments involving HP [1-13 C]pyruvate, a single chamber was prefilled with nicotinamide adenine dinucleotide hydride and lactate dehydrogenase to facilitate the conversion of [1-13 C]pyruvate to [1-13 C]lactate. All experiments were performed on a Siemens Prisma 3T scanner., Results: All the sequence variations localized natural-abundance13 C ethylene glycol and methanol to the appropriate compartment of the multichamber phantom. [1-13 C]pyruvate was detectable in both chambers following the injection of HP [1-13 C]pyruvate, whereas [1-13 C]lactate was only found in the chamber containing nicotinamide adenine dinucleotide hydride and lactate dehydrogenase. The conversion rate from [1-13 C]pyruvate to [1-13 C]lactate (kPL ) was 0.01 s-1 (95% confidence interval [0.00, 0.02])., Conclusion: We have developed and tested a vendor-neutral EPI sequence for imaging HP13 C agents. We have made all of our sequence creation and image reconstruction code freely available online for other investigators to use., (© 2024 International Society for Magnetic Resonance in Medicine.)- Published
- 2024
- Full Text
- View/download PDF
8. Detection of early-stage NASH using non-invasive hyperpolarized 13 C metabolic imaging.
- Author
-
von Morze C, Blazey T, Shaw A, Spees WM, Shoghi KI, and Ohliger MA
- Subjects
- Animals, Liver metabolism, Liver pathology, Liver diagnostic imaging, Mice, Pyruvic Acid metabolism, Male, Methionine metabolism, Gluconeogenesis, Lactic Acid metabolism, Disease Models, Animal, Non-alcoholic Fatty Liver Disease metabolism, Non-alcoholic Fatty Liver Disease pathology, Non-alcoholic Fatty Liver Disease genetics, Carbon Isotopes, Magnetic Resonance Imaging methods
- Abstract
Non-alcoholic steatohepatitis (NASH) is characterized from its early stages by a profound remodeling of the liver microenvironment, encompassing changes in the composition and activities of multiple cell types and associated gene expression patterns. Hyperpolarized (HP)
13 C MRI provides a unique view of the metabolic microenvironment, with potential relevance for early diagnosis of liver disease. Previous studies have detected changes in HP13 C pyruvate to lactate conversion, catalyzed by lactate dehydrogenase (LDH), with experimental liver injury. HP ∝ -ketobutyrate ( ∝ KB) is a close molecular analog of pyruvate with modified specificity for LDH isoforms, specifically attenuated activity with their LDHA-expressed subunits that dominate liver parenchyma. Building on recent results with pyruvate, we investigated HP ∝ KB in methionine-choline deficient (MCD) diet as a model of early-stage NASH. Similarity of results between this new agent and pyruvate (~ 50% drop in cytoplasmic reducing capacity), interpreted together with gene expression data from the model, suggests that changes are mediated through broad effects on intermediary metabolism. Plausible mechanisms are depletion of the lactate pool by upregulation of gluconeogenesis (GNG) and pentose phosphate pathway (PPP) flux, and a possible shift toward increased lactate oxidation. These changes may reflect high levels of oxidative stress and/or shifting macrophage populations in NASH., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF
9. Brain aerobic glycolysis and resilience in Alzheimer disease.
- Author
-
Goyal MS, Blazey T, Metcalf NV, McAvoy MP, Strain JF, Rahmani M, Durbin TJ, Xiong C, Benzinger TL, Morris JC, Raichle ME, and Vlassenko AG
- Subjects
- Young Adult, Humans, Positron-Emission Tomography, Brain metabolism, Amyloid beta-Peptides metabolism, Amyloid metabolism, Amyloidogenic Proteins, Glycolysis, Alzheimer Disease pathology, Cognitive Dysfunction pathology
- Abstract
The distribution of brain aerobic glycolysis (AG) in normal young adults correlates spatially with amyloid-beta (Aβ) deposition in individuals with symptomatic and preclinical Alzheimer disease (AD). Brain AG decreases with age, but the functional significance of this decrease with regard to the development of AD symptomatology is poorly understood. Using PET measurements of regional blood flow, oxygen consumption, and glucose utilization-from which we derive AG-we find that cognitive impairment is strongly associated with loss of the typical youthful pattern of AG. In contrast, amyloid positivity without cognitive impairment was associated with preservation of youthful brain AG, which was even higher than that seen in cognitively unimpaired, amyloid negative adults. Similar findings were not seen for blood flow nor oxygen consumption. Finally, in cognitively unimpaired adults, white matter hyperintensity burden was found to be specifically associated with decreased youthful brain AG. Our results suggest that AG may have a role in the resilience and/or response to early stages of amyloid pathology and that age-related white matter disease may impair this process.
- Published
- 2023
- Full Text
- View/download PDF
10. Increased white matter glycolysis in humans with cerebral small vessel disease.
- Author
-
Brier MR, Blazey T, Raichle ME, Morris JC, Benzinger TLS, Vlassenko AG, Snyder AZ, and Goyal MS
- Subjects
- Humans, Tomography, X-Ray Computed, White Matter diagnostic imaging, Cerebral Small Vessel Diseases diagnostic imaging, Stroke pathology, Cognitive Dysfunction pathology
- Abstract
White matter lesions in cerebral small vessel disease are related to ischemic injury and increase the risk of stroke and cognitive decline. Pathological changes due to cerebral small vessel disease are increasingly recognized outside of discrete lesions, but the metabolic alterations in nonlesional tissue has not been described. Aerobic glycolysis is critical to white matter myelin homeostasis and repair. In this study, we examined cerebral metabolism of glucose and oxygen as well as blood flow in individuals with and without cerebral small vessel disease using multitracer positron emission tomography. We show that glycolysis is relatively elevated in nonlesional white matter in individuals with small vessel disease relative to healthy, age-matched controls. On the other hand, in young healthy individuals, glycolysis is relatively low in areas of white matter susceptible to lesion formation. These results suggest that increased white matter glycolysis is a marker of pathology associated with small vessel disease., (© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.)
- Published
- 2022
- Full Text
- View/download PDF
11. Multi-band echo-planar spectroscopic imaging of hyperpolarized 13 C probes in a compact preclinical PET/MR scanner.
- Author
-
von Morze C, Blazey T, Baeza R, Garipov R, Whitehead T, Reed GD, Garbow JR, and Shoghi KI
- Subjects
- Animals, Carbon Isotopes, Magnetic Resonance Imaging methods, Phantoms, Imaging, Positron-Emission Tomography methods, Rats, Echo-Planar Imaging methods, Pyruvic Acid metabolism
- Abstract
Purpose: Hyperpolarized (HP)
13 C MRI has enabled real-time imaging of specific enzyme-catalyzed metabolic reactions, but advanced pulse sequences are necessary to capture the dynamic, localized metabolic information. Herein we describe the design, implementation, and testing of a rapid and efficient HP13 C pulse sequence strategy on a cryogen-free simultaneous positron emission tomography/MR molecular imaging platform with compact footprint., Methods: We developed an echo planar spectroscopic imaging pulse sequence incorporating multi-band spectral-spatial radiofrequency (SSRF) pulses for spatially coregistered excitation of13 C metabolites with differential individual flip angles. Excitation profiles were measured in phantoms, and the SSRF-echo planar spectroscopic imaging sequence was tested in rats in vivo and compared to conventional echo planar spectroscopic imaging. The new sequence was applied for 2D dynamic metabolic imaging of HP [1-13 C]pyruvate and its molecular analog [1-13 C] α -ketobutyrate at a spatial resolution of 5 mm × 5 mm × 20 mm and temporal resolution of 4 s. We also obtained simultaneous18 F-fluorodeoxyglucose positron emission tomography data for comparison with HP [1-13 C]pyruvate data acquired during the same scan session., Results: Measured SSRF excitation profiles corresponded well to Bloch simulations. Multi-band SSRF excitation facilitated efficient sampling of the multi-spectral kinetics of [1-13 C]pyruvate and [1-13 C] α - ketobutyrate . Whereas high pyruvate to lactate conversion was observed in liver, corresponding reduction of α -ketobutyrate to [1-13 C] α -hydroxybutyrate ( α HB) was largely restricted to the kidneys and heart, consistent with the known expression pattern of lactate dehydrogenase B., Conclusion: Advanced13 C SSRF imaging approaches are feasible on our compact positron emission tomography/MR platform, maximizing the potential of HP13 C technology and facilitating direct comparison with positron emission tomography., (© 2021 International Society for Magnetic Resonance in Medicine.)- Published
- 2022
- Full Text
- View/download PDF
12. Metabolite-Specific Echo-Planar Imaging of Hyperpolarized [1- 13 C]Pyruvate at 4.7 T.
- Author
-
Blazey T, Reed GD, Garbow JR, and von Morze C
- Subjects
- Animals, Lactic Acid, Phantoms, Imaging, Radio Waves, Rats, Echo-Planar Imaging, Pyruvic Acid
- Abstract
Although hyperpolarization (HP) greatly increases the sensitivity of
13 C MR, the usefulness of HP in vivo is limited by the short lifetime of HP agents. To address this limitation, we developed an echo-planar (EPI) sequence with spectral-spatial radiofrequency (SSRF) pulses for fast and efficient metabolite-specific imaging of HP [1-13 C]pyruvate and [1-13 C]lactate at 4.7 T. The spatial and spectral selectivity of each SSRF pulse was verified using simulations and phantom testing. EPI and CSI imaging of the rat abdomen were compared in the same rat after injecting HP [1-13 C]pyruvate. A procedure was also developed to automatically set the SSRF excitation pulse frequencies based on real-time scanner feedback. The most significant results of this study are the demonstration that a greater spatial and temporal resolution is attainable by metabolite-specific EPI as compared with CSI, and the enhanced lifetime of the HP signal in EPI, which is attributable to the independent flip angle control between metabolites. Real-time center frequency adjustment was also highly effective for minimizing off-resonance effects. To the best of our knowledge, this is the first demonstration of metabolite-specific HP13 C EPI at 4.7 T. In conclusion, metabolite-specific EPI using SSRF pulses is an effective way to image HP [1-13 C]pyruvate and [1-13 C]lactate at 4.7 T.- Published
- 2021
- Full Text
- View/download PDF
13. Comparison of hyperpolarized 13 C and non-hyperpolarized deuterium MRI approaches for imaging cerebral glucose metabolism at 4.7 T.
- Author
-
von Morze C, Engelbach JA, Blazey T, Quirk JD, Reed GD, Ippolito JE, and Garbow JR
- Subjects
- Animals, Carbon Isotopes, Deuterium, Glucose, Neuroimaging, Rats, Magnetic Resonance Imaging, Pyruvic Acid
- Abstract
Purpose: The purpose of this study was to directly compare two isotopic metabolic imaging approaches, hyperpolarized (HP)
13 C MRI and deuterium metabolic imaging (DMI), for imaging specific closely related segments of cerebral glucose metabolism at 4.7 T., Methods: Comparative HP-13 C and DMI neuroimaging experiments were conducted consecutively in normal rats during the same scanning session. Localized conversions of [1-13 C]pyruvate and [6,6-2 H2 ]glucose to their respective downstream metabolic products were measured by spectroscopic imaging, using an identical 2D-CSI sequence with parameters optimized for the respective experiments. To facilitate direct comparison, a pair of substantially equivalent 2.5-cm double-tuned X/1 H RF surface coils was developed. For improved results, multidimensional low-rank reconstruction was applied to denoise the raw DMI data., Results: Localized conversion of HP [1-13 C]pyruvate to [1-13 C]lactate, and [6,6-2 H2 ]glucose to [3,3-2 H2 ]lactate and Glx-d (glutamate and glutamine), was detected in rat brain by spectroscopic imaging at 4.7 T. The SNR and spatial resolution of HP-13 C MRI was superior to DMI but limited to a short time window, whereas the lengthy DMI acquisition yielded maps of not only lactate, but also Glx production, albeit with relatively poor spectral discrimination between metabolites at this field strength. Across the individual rats, there was an apparent inverse correlation between cerebral production of HP [1-13 C]lactate and Glx-d, along with a trend toward increased [3,3-2 H2 ]lactate., Conclusion: The HP-13 C MRI and DMI methods are both feasible at 4.7 T and have significant potential for metabolic imaging of specific segments of glucose metabolism., (© 2020 International Society for Magnetic Resonance in Medicine.)- Published
- 2021
- Full Text
- View/download PDF
14. 15 N-carnitine, a novel endogenous hyperpolarized MRI probe with long signal lifetime.
- Author
-
von Morze C, Engelbach JA, Reed GD, Chen AP, Quirk JD, Blazey T, Mahar R, Malloy CR, Garbow JR, and Merritt ME
- Subjects
- Animals, Radio Waves, Rats, Tissue Distribution, Carnitine, Magnetic Resonance Imaging
- Abstract
Purpose: The purpose of this study was to investigate hyperpolarization and in vivo imaging of [
15 N]carnitine, a novel endogenous MRI probe with long signal lifetime., Methods: L-[15 N]carnitine-d9 was hyperpolarized by the method of dynamic nuclear polarization followed by rapid dissolution. The T1 signal lifetimes were estimated in aqueous solution and in vivo following intravenous injection in rats, using a custom-built dual-tuned15 N/1 H RF coil at 4.7 T.15 N chemical shift imaging and15 N fast spin-echo images of rat abdomen were acquired 3 minutes after [15 N]carnitine injection., Results: Estimated T1 times of [15 N]carnitine at 4.7 T were 210 seconds (in H2 O) and 160 seconds (in vivo), with an estimated polarization level of 10%. Remarkably, the [15 N]carnitine coherence was detectable in rat abdomen for 5 minutes after injection for the nonlocalized acquisition. No downstream metabolites were detected on localized or nonlocalized15 N spectra. Diffuse liver enhancement was detected on15 N fast spin-echo imaging 3 minutes after injection, with mean hepatic SNR of 18 ± 5 at a spatial resolution of 4 × 4 mm., Conclusion: This study showed the feasibility of hyperpolarizing and imaging the biodistribution of HP [15 N]carnitine., (© 2020 International Society for Magnetic Resonance in Medicine.)- Published
- 2021
- Full Text
- View/download PDF
15. Quantitative positron emission tomography reveals regional differences in aerobic glycolysis within the human brain.
- Author
-
Blazey T, Snyder AZ, Su Y, Goyal MS, Lee JJ, Vlassenko AG, Arbeláez AM, and Raichle ME
- Subjects
- Adult, Brain blood supply, Gray Matter metabolism, Humans, Male, Oxidative Phosphorylation, Oxygen metabolism, Positron-Emission Tomography methods, Brain metabolism, Glucose metabolism, Glycolysis
- Abstract
Glucose and oxygen metabolism are tightly coupled in the human brain, with the preponderance of the brain's glucose supply used to generate ATP via oxidative phosphorylation. A fraction of glucose is consumed outside of oxidative phosphorylation despite the presence of sufficient oxygen to do so. We refer to this process as aerobic glycolysis. A recent positron emission tomography study reported that aerobic glycolysis is uniform within gray matter. Here, we analyze the same data and demonstrate robust regional differences in aerobic glycolysis within gray matter, a finding consistent with previously published data.
- Published
- 2019
- Full Text
- View/download PDF
16. Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease.
- Author
-
Wang Q, Wang Y, Liu J, Sutphen CL, Cruchaga C, Blazey T, Gordon BA, Su Y, Chen C, Shimony JS, Ances BM, Cairns NJ, Fagan AM, Morris JC, and Benzinger TLS
- Subjects
- Aged, Alzheimer Disease cerebrospinal fluid, Alzheimer Disease pathology, Amyloid beta-Peptides cerebrospinal fluid, Biomarkers, Female, Humans, Inflammation cerebrospinal fluid, Inflammation pathology, Longitudinal Studies, Male, Middle Aged, Peptide Fragments cerebrospinal fluid, White Matter pathology, Alzheimer Disease diagnostic imaging, Diffusion Magnetic Resonance Imaging methods, Image Processing, Computer-Assisted methods, Inflammation diagnostic imaging, Prodromal Symptoms, White Matter diagnostic imaging
- Abstract
Interest in understanding the roles of white matter (WM) inflammation and damage in the pathophysiology of Alzheimer disease (AD) has been growing significantly in recent years. However, in vivo magnetic resonance imaging (MRI) techniques for imaging inflammation are still lacking. An advanced diffusion-based MRI method, neuro-inflammation imaging (NII), has been developed to clinically image and quantify WM inflammation and damage in AD. Here, we employed NII measures in conjunction with cerebrospinal fluid (CSF) biomarker classification (for β-amyloid (Aβ) and neurodegeneration) to evaluate 200 participants in an ongoing study of memory and aging. Elevated NII-derived cellular diffusivity was observed in both preclinical and early symptomatic phases of AD, while disruption of WM integrity, as detected by decreased fractional anisotropy (FA) and increased radial diffusivity (RD), was only observed in the symptomatic phase of AD. This may suggest that WM inflammation occurs earlier than WM damage following abnormal Aβ accumulation in AD. The negative correlation between NII-derived cellular diffusivity and CSF Aβ
42 level (a marker of amyloidosis) may indicate that WM inflammation is associated with increasing Aβ burden. NII-derived FA also negatively correlated with CSF t-tau level (a marker of neurodegeneration), suggesting that disruption of WM integrity is associated with increasing neurodegeneration. Our findings demonstrated the capability of NII to simultaneously image and quantify WM cellularity changes and damage in preclinical and early symptomatic AD. NII may serve as a clinically feasible imaging tool to study the individual and composite roles of WM inflammation and damage in AD., (Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
17. A systematic meta-analysis of oxygen-to-glucose and oxygen-to-carbohydrate ratios in the resting human brain.
- Author
-
Blazey T, Snyder AZ, Goyal MS, Vlassenko AG, and Raichle ME
- Subjects
- Bayes Theorem, Brain metabolism, Female, Humans, Lactic Acid metabolism, Male, Middle Aged, Oxidative Phosphorylation, Oxygen Consumption, Young Adult, Brain physiology, Carbohydrate Metabolism, Glucose metabolism, Oxygen metabolism, Rest physiology
- Abstract
Glucose is the predominant fuel supporting brain function. If the brain's entire glucose supply is consumed by oxidative phosphorylation, the molar ratio of oxygen to glucose consumption (OGI) is equal to 6. An OGI of less than 6 is evidence of non-oxidative glucose metabolism. Several studies have reported that the OGI in the resting human brain is less than 6.0, but the exact value remains uncertain. Additionally, it is not clear if lactate efflux accounts for the difference between OGI and its theoretical value of 6.0. To address these issues, we conducted a meta-analysis of OGI and oxygen-to-carbohydrate (glucose + 0.5*lactate; OCI) ratios in healthy young and middle-aged adults. We identified 47 studies that measured at least one of these ratios using arterio-venous differences of glucose, lactate, and oxygen. Using a Bayesian random effects model, the population median OGI was 5.46 95% credible interval (5.25-5.66), indicating that approximately 9% of the brain's glucose metabolism is non-oxidative. The population median OCI was 5.60 (5.36-5.84), suggesting that lactate efflux does not account for all non-oxidative glucose consumption. Significant heterogeneity across studies was observed, which implies that further work is needed to characterize how demographic and methodological factors influence measured cerebral metabolic ratios., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2018
- Full Text
- View/download PDF
18. Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology.
- Author
-
Gordon BA, Blazey T, Su Y, Fagan AM, Holtzman DM, Morris JC, and Benzinger TL
- Subjects
- Aged, Alzheimer Disease classification, Aniline Compounds, Biomarkers, Female, Humans, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Positron-Emission Tomography, Prodromal Symptoms, Thiazoles, Alzheimer Disease diagnostic imaging, Alzheimer Disease metabolism, Amyloid beta-Peptides metabolism, Disease Progression, Hippocampus diagnostic imaging, tau Proteins cerebrospinal fluid
- Abstract
Importance: Preclinical Alzheimer disease (AD) can be staged using a 2-factor model denoting the presence or absence of β-amyloid (Aβ+/-) and neurodegeneration (ND+/-). The association of these stages with longitudinal biomarker outcomes is unknown., Objective: To examine whether longitudinal Aβ accumulation and hippocampal atrophy differ based on initial preclinical staging., Design, Setting, and Participants: This longitudinal population-based cohort study used data collected at the Knight Alzheimer Disease Research Center, Washington University, St Louis, Missouri, from December 1, 2006, to June 31, 2015. Cognitively normal older adults (n = 174) were recruited from the longitudinal Adult Children Study and Healthy Aging and Senile Dementia Study at the Knight Alzheimer Disease Research Center. At baseline, all participants had magnetic resonance imaging (MRI) scans, positron emission tomography (PET) scans with carbon 11-labeled Pittsburgh Compound B (PiB), and cerebrospinal fluid assays of tau and phosphorylated tau (ptau) acquired within 12 months. Using the baseline biomarkers, individuals were classified into preclinical stage 0 (Aβ-/ND-), 1 (Aβ+/ND-), or 2+ (Aβ+/ND+) or suspected non-AD pathophysiology (SNAP; Aβ-/ND+)., Main Outcomes and Measures: Subsequent longitudinal accumulation of Aβ assessed with PiB PET and loss of hippocampal volume assessed with MRI in each group., Results: Among the 174 participants (81 men [46.6%]; 93 women [53.4%]; mean [SD] age, 65.7 [8.9] years), a proportion (14%-17%) of individuals with neurodegeneration alone (SNAP) later demonstrated Aβ+. The rates of Aβ accumulation and loss of hippocampal volume in individuals with SNAP were indistinguishable from those without any pathologic features at baseline (for Aβ accumulation: when hippocampal volume was used to define ND, t = 0.00 [P > .99]; when tau and ptau were used to define ND, t = -0.02 [P = .98]; for loss of hippocampal volume: when hippocampal volume was used to define ND, t = -1.34 [P = .18]; when tau and ptau were used to define ND, t = 0.84 [P = .40]). Later preclinical stages (stages 1 and 2+) had elevated Aβ accumulation. Using hippocampal volume to define ND, individuals with stage 1 had accelerated Aβ accumulation relative to stage 0 (t = 11.06; P < .001), stage 2+ (t = 2.10; P = .04), and SNAP (t = 9.32; P < .001), and those with stage 2+ had accelerated Aβ accumulation relative to stage 0 (t = 4.38; P < .001) and SNAP (t = 4.08; P < .001). When ND was defined using tau and ptau, individuals with stage 2+ had accelerated Aβ accumulation relative to stage 0 (t = 4.96) and SNAP (t = 4.06), and those with stage 1 had accelerated Aβ accumulation relative to stage 0 (t = 8.44) and SNAP (t = 6.61) (P < .001 for all comparisons). When ND was defined using cerebrospinal fluid biomarkers, individuals with stage 2+ had accelerated hippocampal atrophy relative to stage 0 (t = -3.41; P < .001), stage 1 (t = -2.48; P = .03), and SNAP (t = -2.26; P = .03)., Conclusions and Relevance: More advanced preclinical stages of AD have greater longitudinal Aβ accumulation. SNAP appears most likely to capture inherent individual variability in brain structure or to represent comorbid pathologic features rather than early emerging AD. Low hippocampal volumes or elevated levels of tau or ptau in isolation may not accurately represent ongoing neurodegenerative processes., Competing Interests: Disclosures: No other disclosures were reported.
- Published
- 2016
- Full Text
- View/download PDF
19. The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging.
- Author
-
Gordon BA, Friedrichsen K, Brier M, Blazey T, Su Y, Christensen J, Aldea P, McConathy J, Holtzman DM, Cairns NJ, Morris JC, Fagan AM, Ances BM, and Benzinger TL
- Subjects
- Aged, Aged, 80 and over, Biomarkers metabolism, Female, Humans, Male, Alzheimer Disease cerebrospinal fluid, Alzheimer Disease diagnostic imaging, Amyloid beta-Peptides cerebrospinal fluid, Carbolines, Peptide Fragments cerebrospinal fluid, Positron-Emission Tomography methods, tau Proteins metabolism
- Abstract
The two primary molecular pathologies in Alzheimer's disease are amyloid-β plaques and tau-immunoreactive neurofibrillary tangles. Investigations into these pathologies have been restricted to cerebrospinal fluid assays, and positron emission tomography tracers that can image amyloid-β plaques. Tau tracers have recently been introduced into the field, although the utility of the tracer and its relationship to other Alzheimer biomarkers are still unknown. Here we examined tau deposition in 41 cognitively normal and 11 cognitively impaired older adults using the radioactive tau ligand (18)F-AV-1451 (previously known as T807) who also underwent a lumbar puncture to assess cerebrospinal fluid levels of total tau (t-tau), phosphorylated tau181 (p-tau181) and amyloid-β42 Voxel-wise statistical analyses examined spatial patterns of tau deposition associated with cognitive impairment. We then related the amount of tau tracer uptake to levels of cerebrospinal fluid biomarkers. All analyses controlled for age and gender and, when appropriate, the time between imaging and lumbar puncture assessments. Symptomatic individuals (Clinical Dementia Rating > 0) demonstrated markedly increased levels of tau tracer uptake. This elevation was most prominent in the temporal lobe and temporoparietal junction, but extended more broadly into parietal and frontal cortices. In the entire cohort, there were significant relationships among all cerebrospinal fluid biomarkers and tracer uptake, notably for tau-related cerebrospinal fluid markers. After controlling for levels of amyloid-β42, the correlations with tau uptake were r = 0.490 (P < 0.001) for t-tau and r = 0.492 (P < 0.001) for p-tau181 Within the cognitively normal cohort, levels of amyloid-β42, but not t-tau or p-tau181, were associated with elevated tracer binding that was confined primarily to the medial temporal lobe and adjacent neocortical regions. AV-1451 tau binding in the medial temporal, parietal, and frontal cortices is correlated with tau-related cerebrospinal fluid measures. In preclinical Alzheimer's disease, there is focal tauopathy in the medial temporal lobes and adjacent cortices., (© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF
20. Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkers.
- Author
-
Gordon BA, Zacks JM, Blazey T, Benzinger TL, Morris JC, Fagan AM, Holtzman DM, and Balota DA
- Subjects
- Aged, Alzheimer Disease psychology, Amyloid beta-Peptides cerebrospinal fluid, Biomarkers cerebrospinal fluid, Cognition physiology, Disease Progression, Female, Humans, Male, Middle Aged, Peptide Fragments cerebrospinal fluid, tau Proteins cerebrospinal fluid, Alzheimer Disease diagnosis, Alzheimer Disease pathology, Attention physiology, Brain pathology, Brain physiology, Magnetic Resonance Imaging, Neuropsychological Tests
- Abstract
There is a growing emphasis on examining preclinical levels of Alzheimer's disease (AD)-related pathology in the absence of cognitive impairment. Previous work examining biomarkers has focused almost exclusively on memory, although there is mounting evidence that attention also declines early in disease progression. In the current experiment, 2 attentional control tasks were used to examine alterations in task-evoked functional magnetic resonance imaging data related to biomarkers of AD pathology. Seventy-one cognitively normal individuals (females = 44, mean age = 63.5 years) performed 2 attention-demanding cognitive tasks in a design that modeled both trial- and task-level functional magnetic resonance imaging changes. Biomarkers included amyloid β42, tau, and phosphorylated tau measured from cerebrospinal fluid and positron emission tomography measures of amyloid deposition. Both tasks elicited widespread patterns of activation and deactivation associated with large task-level manipulations of attention. Importantly, results from both tasks indicated that higher levels of tau and phosphorylated tau pathologies were associated with block-level overactivations of attentional control areas. This suggests early alteration in attentional control with rising levels of AD pathology., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
21. Lag threads organize the brain's intrinsic activity.
- Author
-
Mitra A, Snyder AZ, Blazey T, and Raichle ME
- Subjects
- Adult, Cortical Synchronization, Humans, Male, Radiography, Brain diagnostic imaging, Brain physiology, Magnetic Resonance Imaging, Models, Neurological, Nerve Net diagnostic imaging, Nerve Net physiology
- Abstract
It has been widely reported that intrinsic brain activity, in a variety of animals including humans, is spatiotemporally structured. Specifically, propagated slow activity has been repeatedly demonstrated in animals. In human resting-state fMRI, spontaneous activity has been understood predominantly in terms of zero-lag temporal synchrony within widely distributed functional systems (resting-state networks). Here, we use resting-state fMRI from 1,376 normal, young adults to demonstrate that multiple, highly reproducible, temporal sequences of propagated activity, which we term "lag threads," are present in the brain. Moreover, this propagated activity is largely unidirectional within conventionally understood resting-state networks. Modeling experiments show that resting-state networks naturally emerge as a consequence of shared patterns of propagation. An implication of these results is that common physiologic mechanisms may underlie spontaneous activity as imaged with fMRI in humans and slowly propagated activity as studied in animals.
- Published
- 2015
- Full Text
- View/download PDF
22. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease.
- Author
-
Wang L, Benzinger TL, Hassenstab J, Blazey T, Owen C, Liu J, Fagan AM, Morris JC, and Ances BM
- Subjects
- Aged, Aged, 80 and over, Alzheimer Disease cerebrospinal fluid, Alzheimer Disease pathology, Alzheimer Disease physiopathology, Atrophy pathology, Biomarkers cerebrospinal fluid, Cerebral Cortex physiopathology, Cohort Studies, Female, Hippocampus physiopathology, Humans, Magnetic Resonance Imaging, Male, Alzheimer Disease diagnosis, Amyloid beta-Peptides cerebrospinal fluid, Cerebral Cortex pathology, Hippocampus pathology, Peptide Fragments cerebrospinal fluid, Prodromal Symptoms, tau Proteins cerebrospinal fluid
- Abstract
Objectives: To determine whether an MRI-based Alzheimer disease (AD) signature biomarker can detect tau-related neurodegeneration in preclinical AD, and to assess whether AD signature cortical thinning is associated with cognitive changes in cognitively normal (CN) older individuals., Methods: In a large cohort of CN individuals (n = 188), we measured the hippocampal volume and cortical thickness within independently defined AD signature regions. We cross-sectionally assessed the associations between AD signature cortical thinning or hippocampal atrophy with CSF biomarkers of tau (increased tau) and β-amyloid (Aβ) (decreased Aβ42). We also examined the impact of AD signature cortical thinning or other biomarker changes (i.e., hippocampal atrophy, reduced CSF Aβ42, or increased CSF tau) on cognitive performance in CN individuals., Results: Elevated CSF tau was associated with AD signature cortical thinning but not hippocampal atrophy. In contrast, decreased CSF Aβ42 was associated with hippocampal loss but not AD signature cortical thinning. In addition, AD signature cortical thinning was associated with lower visuospatial performance. Reduced CSF Aβ42 was related to poorer performance on episodic memory., Conclusions: Spatially distinct neurodegeneration is associated with Aβ and tau pathology in preclinical AD. Aβ deposition and AD signature cortical atrophy independently affect cognition in CN older individuals., (© 2015 American Academy of Neurology.)
- Published
- 2015
- Full Text
- View/download PDF
23. Regional variability in Alzheimer's disease biomarkers.
- Author
-
Gordon BA, Blazey T, and Benzinger TL
- Published
- 2014
- Full Text
- View/download PDF
24. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.
- Author
-
Benzinger TL, Blazey T, Jack CR Jr, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ, Fagan AM, Goate A, Marcus DS, Aisen PS, Christensen JJ, Ercole L, Hornbeck RC, Farrar AM, Aldea P, Jasielec MS, Owen CJ, Xie X, Mayeux R, Brickman A, McDade E, Klunk W, Mathis CA, Ringman J, Thompson PM, Ghetti B, Saykin AJ, Sperling RA, Johnson KA, Salloway S, Correia S, Schofield PR, Masters CL, Rowe C, Villemagne VL, Martins R, Ourselin S, Rossor MN, Fox NC, Cash DM, Weiner MW, Holtzman DM, Buckles VD, Moulder K, and Morris JC
- Subjects
- Adult, Age of Onset, Alzheimer Disease genetics, Aniline Compounds metabolism, Carbon Radioisotopes metabolism, Cohort Studies, Female, Fluorodeoxyglucose F18 metabolism, Genes, Dominant genetics, Humans, Magnetic Resonance Imaging methods, Male, Middle Aged, Models, Biological, Positron-Emission Tomography methods, Regression Analysis, Thiazoles metabolism, Time Factors, Alzheimer Disease pathology, Biomarkers metabolism, Brain metabolism, Brain pathology
- Abstract
Major imaging biomarkers of Alzheimer's disease include amyloid deposition [imaged with [(11)C]Pittsburgh compound B (PiB) PET], altered glucose metabolism (imaged with [(18)F]fluro-deoxyglucose PET), and structural atrophy (imaged by MRI). Recently we published the initial subset of imaging findings for specific regions in a cohort of individuals with autosomal dominant Alzheimer's disease. We now extend this work to include a larger cohort, whole-brain analyses integrating all three imaging modalities, and longitudinal data to examine regional differences in imaging biomarker dynamics. The anatomical distribution of imaging biomarkers is described in relation to estimated years from symptom onset. Autosomal dominant Alzheimer's disease mutation carrier individuals have elevated PiB levels in nearly every cortical region 15 y before the estimated age of onset. Reduced cortical glucose metabolism and cortical thinning in the medial and lateral parietal lobe appeared 10 and 5 y, respectively, before estimated age of onset. Importantly, however, a divergent pattern was observed subcortically. All subcortical gray-matter regions exhibited elevated PiB uptake, but despite this, only the hippocampus showed reduced glucose metabolism. Similarly, atrophy was not observed in the caudate and pallidum despite marked amyloid accumulation. Finally, before hypometabolism, a hypermetabolic phase was identified for some cortical regions, including the precuneus and posterior cingulate. Additional analyses of individuals in which longitudinal data were available suggested that an accelerated appearance of volumetric declines approximately coincides with the onset of the symptomatic phase of the disease.
- Published
- 2013
- Full Text
- View/download PDF
25. Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers.
- Author
-
Potter R, Patterson BW, Elbert DL, Ovod V, Kasten T, Sigurdson W, Mawuenyega K, Blazey T, Goate A, Chott R, Yarasheski KE, Holtzman DM, Morris JC, Benzinger TL, and Bateman RJ
- Subjects
- Adult, Alzheimer Disease blood, Alzheimer Disease genetics, Alzheimer Disease metabolism, Amyloid blood, Amyloid metabolism, Amyloid beta-Peptides blood, Female, Humans, Male, Middle Aged, Mutation, Positron-Emission Tomography, Amyloid beta-Peptides metabolism, Presenilins genetics
- Abstract
Alzheimer's disease (AD) is hypothesized to be caused by an overproduction or reduced clearance of amyloid-β (Aβ) peptide. Autosomal dominant AD (ADAD) caused by mutations in the presenilin (PSEN) gene have been postulated to result from increased production of Aβ42 compared to Aβ40 in the central nervous system (CNS). This has been demonstrated in rodent models of ADAD but not in human mutation carriers. We used compartmental modeling of stable isotope labeling kinetic (SILK) studies in human carriers of PSEN mutations and related noncarriers to evaluate the pathophysiological effects of PSEN1 and PSEN2 mutations on the production and turnover of Aβ isoforms. We compared these findings by mutation status and amount of fibrillar amyloid deposition as measured by positron emission tomography (PET) using the amyloid tracer Pittsburgh compound B (PIB). CNS Aβ42 to Aβ40 production rates were 24% higher in mutation carriers compared to noncarriers, and this was independent of fibrillar amyloid deposits quantified by PET PIB imaging. The fractional turnover rate of soluble Aβ42 relative to Aβ40 was 65% faster in mutation carriers and correlated with amyloid deposition, consistent with increased deposition of Aβ42 into plaques, leading to reduced recovery of Aβ42 in cerebrospinal fluid (CSF). Reversible exchange of Aβ42 peptides with preexisting unlabeled peptide was observed in the presence of plaques. These findings support the hypothesis that Aβ42 is overproduced in the CNS of humans with PSEN mutations that cause AD, and demonstrate that soluble Aβ42 turnover and exchange processes are altered in the presence of amyloid plaques, causing a reduction in Aβ42 concentrations in the CSF.
- Published
- 2013
- Full Text
- View/download PDF
26. Effects of aging and Alzheimer's disease along the longitudinal axis of the hippocampus.
- Author
-
Gordon BA, Blazey T, Benzinger TL, and Head D
- Subjects
- Aged, Aged, 80 and over, Aging psychology, Alzheimer Disease psychology, Female, Humans, Male, Middle Aged, Organ Size, Aging pathology, Alzheimer Disease pathology, Hippocampus pathology
- Abstract
The hippocampus is often treated as a uniform structure, but possesses differential projections to surrounding cortex along its longitudinal axis. This heterogeneity could create varied susceptibility to pathological influences, potentially leading to non-uniform volumetric associations with advancing age and Alzheimer's disease (AD). Previous examinations of aging and AD effects on hippocampal subdivisions have produced highly discrepant findings. To clarify these inconsistencies, we examined the hippocampal head, body, and tail in a large sample of 292 cognitively normal, 37 very mildly demented, and 18 mildly demented individuals, divided into two independent samples. As often done in the literature, we characterized qualitative patterns across these regions, but extended these results by explicitly testing for quantitative differences. In each sample of cognitively normal individuals, the head and body demonstrated greater age effects than the tail. In each sample contrasting AD and cognitively normal individuals, all three regions showed significant volume reductions, with the greatest effect on the head. When examining increasing severity of dementia, the hippocampal head showed progressive volume loss, while the body and tail did not. The patterns of results examining both aging and AD were relatively consistent across the independent samples. These results indicate that there is an anterior-to-posterior gradient of loss within the hippocampus with both advancing age and AD.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.